| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.4 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |